Andrew Murphy

14.6k total citations · 1 hit paper
203 papers, 9.5k citations indexed

About

Andrew Murphy is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Andrew Murphy has authored 203 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Immunology, 77 papers in Molecular Biology and 51 papers in Surgery. Recurrent topics in Andrew Murphy's work include Adipokines, Inflammation, and Metabolic Diseases (31 papers), Immune cells in cancer (30 papers) and Atherosclerosis and Cardiovascular Diseases (27 papers). Andrew Murphy is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (31 papers), Immune cells in cancer (30 papers) and Atherosclerosis and Cardiovascular Diseases (27 papers). Andrew Murphy collaborates with scholars based in Australia, United States and Netherlands. Andrew Murphy's co-authors include Alan R. Tall, Kevin Woollard, Prabhakara R. Nagareddy, Marit Westerterp, Jaye Chin‐Dusting, Laurent Yvan‐Charvet, Dmitri Sviridov, Roslynn A. Stirzaker, Michael J. Kraakman and Dragana Dragoljevic and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Andrew Murphy

195 papers receiving 9.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hyperglycemia Promotes Myelopoiesis and Impairs the Resolution of Atherosclerosis

2013 444 citations Prabhakara R. Nagareddy, Andrew Murphy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Murphy Australia	53	3.3k	3.1k	2.5k	1.9k	1.4k	203	9.5k
Jianglin Fan Japan	51	2.6k 0.8×	1.6k 0.5×	1.8k 0.7×	1.2k 0.7×	1.3k 1.0×	243	8.0k
Robert L. Reddick United States	44	2.3k 0.7×	1.9k 0.6×	2.1k 0.8×	966 0.5×	1.1k 0.8×	148	8.9k
Joseph P. Grande United States	71	4.2k 1.3×	1.5k 0.5×	2.8k 1.1×	939 0.5×	857 0.6×	284	15.0k
Minoru Satoh Japan	65	4.6k 1.4×	4.8k 1.6×	934 0.4×	2.4k 1.3×	1.1k 0.8×	329	14.4k
Ulf Hedin Sweden	52	4.0k 1.2×	3.3k 1.1×	1.7k 0.7×	1.3k 0.7×	1.4k 1.0×	216	10.2k
Imo E. Hoefer Netherlands	52	4.4k 1.3×	1.8k 0.6×	2.6k 1.0×	946 0.5×	2.3k 1.6×	250	9.8k
Carla Zoja Italy	69	3.4k 1.0×	2.4k 0.8×	2.0k 0.8×	735 0.4×	2.4k 1.7×	192	13.3k
Masayuki Yoshida Japan	48	2.9k 0.9×	1.8k 0.6×	1.7k 0.7×	901 0.5×	763 0.5×	370	9.8k
William C. Aird United States	62	6.3k 1.9×	2.9k 0.9×	1.7k 0.7×	2.0k 1.1×	1.4k 1.0×	169	14.1k
Linda L. Demer United States	65	5.0k 1.5×	2.4k 0.8×	3.5k 1.4×	1.7k 0.9×	3.6k 2.5×	162	17.5k

Countries citing papers authored by Andrew Murphy

Since Specialization

Citations

This map shows the geographic impact of Andrew Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Murphy more than expected).

Fields of papers citing papers by Andrew Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Murphy. The network helps show where Andrew Murphy may publish in the future.

Co-authorship network of co-authors of Andrew Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Murphy. A scholar is included among the top collaborators of Andrew Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Murphy. Andrew Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morris, Jacqui, Linda Irvine, Jenna Breckenridge, et al.. (2025). Keeping Active with Texting after Stroke (KATS): a single-arm feasibility and acceptability study of a behavioural intervention to promote community-based physical activity after stroke rehabilitation. BMJ Open. 15(2). e093838–e093838.

Noonan, Jonathan, Laura A. Bienvenu, Pramod Kumar Sharma, et al.. (2025). CTLA-4-Ig Therapy Preserves Cardiac Function Following Myocardial Infarction With Reperfusion. Heart Lung and Circulation. 34. S132–S132.

Mukhamedova, Nigora, Andrew J. Fleetwood, A. Faulkner, et al.. (2025). Targeting the ARF6-dependent recycling pathway to alter lipid rafts and reduce inflammation. Journal of Lipid Research. 66(10). 100900–100900.

Kaiser, Yannick, Mia Ståhle, Nick S. Nurmohamed, et al.. (2023). Atorvastatin lowers 68Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes. Diabetologia. 66(11). 2164–2169. 8 indexed citations

Chen, Yung‐Chih, Manousos Makridakis, Jonathan Noonan, et al.. (2023). Quantitative proteomic landscape of unstable atherosclerosis identifies molecular signatures and therapeutic targets for plaque stabilization. Communications Biology. 6(1). 265–265. 17 indexed citations

Dragoljevic, Dragana, Gerard Pernes, Cynthia Louis, et al.. (2023). Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis. Clinical & Translational Immunology. 12(4). e1446–e1446. 4 indexed citations

Dragoljevic, Dragana, Camilla Bertuzzo Veiga, Danielle L. Michell, et al.. (2021). A spontaneously hypertensive diet-induced atherosclerosis-prone mouse model of metabolic syndrome. Biomedicine & Pharmacotherapy. 139. 111668–111668. 3 indexed citations

Johnson, Jillian, Gopalkrishna Sreejit, Albert Dahdah, et al.. (2021). Oxidative Stress in Neutrophils: Implications for Diabetic Cardiovascular Complications. Antioxidants and Redox Signaling. 36(10-12). 652–666. 36 indexed citations

Veiga, Camilla Bertuzzo, et al.. (2021). Myelodysplasia Syndrome, Clonal Hematopoiesis and Cardiovascular Disease. Cancers. 13(8). 1968–1968. 11 indexed citations

10.

Hanssen, Nordin M.J., Bart Spaetgens, Prabhakara R. Nagareddy, & Andrew Murphy. (2021). DAMPening Mortality in COVID-19. Circulation. 143(10). 971–973. 6 indexed citations

11.

Sreejit, Gopalkrishna, Jillian Johnson, Albert Dahdah, et al.. (2021). Neutrophils in cardiovascular disease: warmongers, peacemakers, or both?. Cardiovascular Research. 118(12). 2596–2609. 51 indexed citations

12.

Su, Qi, Sun Y. Kim, Ye Zhou, et al.. (2021). Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver. iScience. 24(11). 103233–103233. 72 indexed citations

13.

Ke, Francine, Graeme I. Lancaster, Stephanie Grabow, Andrew Murphy, & Andreas Strasser. (2020). Combined reduction in the expression of MCL-1 and BCL-2 reduces organismal size in mice. Cell Death and Disease. 11(3). 185–185. 5 indexed citations

14.

Sreejit, Gopalkrishna, Andrew J. Fleetwood, Andrew Murphy, & Prabhakara R. Nagareddy. (2020). Origins and diversity of macrophages in health and disease. Clinical & Translational Immunology. 9(12). e1222–e1222. 68 indexed citations

15.

Sreejit, Gopalkrishna, Ahmed Abdel Latif, Andrew Murphy, & Prabhakara R. Nagareddy. (2020). Emerging roles of neutrophil-borne S100A8/A9 in cardiovascular inflammation. Pharmacological Research. 161. 105212–105212. 47 indexed citations

16.

Qin, Cheng Xue, Sarah Rosli, Minh Deo, et al.. (2019). Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac2-26, Against Myocardial Infarction. Frontiers in Pharmacology. 10. 269–269. 31 indexed citations

17.

Fang, Longhou, et al.. (2019). Hematopoiesis is regulated by cholesterol efflux pathways and lipid rafts: connections with cardiovascular diseases. Journal of Lipid Research. 61(5). 667–675. 36 indexed citations

18.

Kleiner, Sandra, Daniel R. Gomez, Erqian Na, et al.. (2018). Mice harboring the human SLC30A8 R138X loss-of-function mutation have increased insulin secretory capacity. Proceedings of the National Academy of Sciences. 115(32). E7642–E7649. 40 indexed citations

19.

Murphy, Andrew, Tamara A. Pagler, Mani Akhtari, & Alan R. Tall. (2010). Abstract 19263: Enhancing Cholesterol Efflux Pathways Suppresses Hematopoietic Stem Cell Proliferation and Monocytosis in apoE−/− Mice. Circulation. 122. 1 indexed citations

20.

McCann, William R., et al.. (1982). A large normal-fault earthquake in the overriding wedge of the Lesser Antilles subduction zone: The earthquake of 8 October 1974. Bulletin of the Seismological Society of America. 72. 2267–2283. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact